22,275 Shares in Exponent, Inc. $EXPO Bought by Jupiter Topco LLC

Jupiter Topco LLC purchased a new position in shares of Exponent, Inc. (NASDAQ:EXPO) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 22,275 shares of the business services provider’s stock, valued at approximately $1,309,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Canada Pension Plan Investment Board bought a new position in Exponent during the second quarter worth about $5,988,000. Legal & General Group Plc bought a new position in shares of Exponent during the 2nd quarter worth approximately $4,144,000. The Manufacturers Life Insurance Company acquired a new position in shares of Exponent during the 2nd quarter worth approximately $2,572,000. Sanctuary Advisors LLC bought a new stake in Exponent in the 2nd quarter valued at $1,104,000. Finally, Elevation Point Wealth Partners LLC acquired a new stake in shares of Exponent during the 2nd quarter worth about $221,000. Institutional investors own 92.37% of the company’s stock.

Exponent Stock Performance

Shares of NASDAQ:EXPO opened at $68.35 on Friday. Exponent, Inc. has a 52 week low of $51.91 and a 52 week high of $81.95. The firm has a market cap of $3.25 billion, a PE ratio of 30.65 and a beta of 0.68. The firm’s fifty day moving average is $65.52 and its 200-day moving average is $64.46.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, July 30th. The business services provider reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.55 by $0.05. The business had revenue of $171.61 million during the quarter, compared to the consensus estimate of $144.99 million. Exponent had a return on equity of 31.48% and a net margin of 17.67%.Exponent’s quarterly revenue was up 12.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.52 earnings per share. Sell-side analysts forecast that Exponent, Inc. will post 2.31 EPS for the current year.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Friday, September 4th will be given a $0.31 dividend. The ex-dividend date is Friday, September 4th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.8%. Exponent’s payout ratio is 55.61%.

Insider Activity at Exponent

In other news, CEO Catherine Corrigan sold 1,707 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $66.28, for a total transaction of $113,139.96. Following the completion of the sale, the chief executive officer directly owned 129,108 shares in the company, valued at $8,557,278.24. This represents a 1.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on EXPO shares. UBS Group set a $72.00 target price on Exponent and gave the company a “neutral” rating in a research report on Friday, July 31st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a research report on Friday, July 17th. Finally, JPMorgan Chase & Co. lifted their target price on Exponent from $80.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $81.00.

Exponent Company Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.